Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatelite markers and capillary electrophoresis with flourescence detection: The Frankfurt experience

Leukemia

Volumn 17, Issue 1, 2003, Pages 232-236

  Koehl, U ^a   Beck, O ^a   Esser, R ^a   Seifried, E ^b   Klingebiel, T ^a   Schwabe, D ^a   Seidl, C ^b  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b Institute of Transfusion Medicine and Immunohaematology   (Germany)

Author keywords

Mixed chimerism testing in allogeneic stem cell transplatation

Indexed keywords

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANALYZER; ARTICLE; CAPILLARY ELECTROPHORESIS; CHIMERA; CHROMOSOME ANALYSIS; DNA EXTRACTION; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; GENE AMPLIFICATION; GERMANY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MICROSATELLITE MARKER; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TANDEM REPEAT; THALASSEMIA;

EID: 0037268943     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402760     Document Type: Article

References (28)

1. Dubovsky J, Daxberger H, Fritsch G, Printz D, Peters C, Matthes-Martin S, Gadner H, Lion T. Kinetic of chimerism during the early post-transplant period in pediatric patients with malignant and non-malignant hematologic disorders: Implications for timely detection of engraftment, graft failure and rejection. Leukemia 1999; 13: 2060-2069.
2. Bader P, Klingebiel T, Schaudt A, Theurer-Mainka U, Handgretinger R, Niethammer D, Beck J. Prevention of relapse in pediatric patients with acute leukemias and MDS after allogeneic SCT by early immunotherapy initiated on the basis of increasing mixed chimerism: a single center experience of 12 children. Leukemia 1999; 13: 2079-2086.
3. Bader P, Stoll K, Huber S, Geiselhart A, Handgretinger R, Niemeyer C, Einsele H, Schlegel PG, Niethammer D, Beck J, Klingebiel T. Characterization of lineages specific in patients with acute leukemia and MDS after allogeneic SCT before and after relapse. Br J Haematol 2000; 108: 761-768.
4. Lion T, Daxberger H, Dubovsky J, Filipcik P, Fritsch G, Printz D, Peters C, Matthes-Martin S, Lawitschka A, Gadner H. Analysis of chimerism within specific leukocyte subsets for detection of residual or recurrent leukemia in pediatric patients after allogeneic stem cell transplantation. Leukemia 2001; 15: 307-310.
5. Thiede C, Bornhäuser M, Oelschlägel U, Brendel C, Leo R, Daxherger H, Mohr B, Florek M, Kroschinsky F, Geissler G, Naumann R, Ritter M, Prange-Krex G, Lion T, Neubauer A, Ehninger G. Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation (BSCT) using multiplex PCR amplification of short-tandem repeat-markers. Leukemia 2001; 15: 293-302.
6. Thiede C, Lion T. Quantitative analysis of chimerism after allogeneic stem cell transplantation using multiplex PCR amplification of short tandem repeat markers and fluorescence detection. Leukemia 2001; 15: 303-306.
7. Gonzalez M, Lopez-Perez R, Perez-Simon JA, Garcia-Sanz R, San Miguel JF. Comments concerning chimerism studies. Leukemia 2001; 15: 1986-1988.
8. Beck O, Koehl U, Gruettner HP, Schwabe D, Klingebiel T, Seifried E, Seidl C. The use of chimerism monitoring for adaptive immunotherapy can prevent early graft rejection post allogeneic stem cell transplantation. Haematology J 2001; 1: 210.
9. Mattsson J, Uzunel M, Tammik L, Aschan J, Rindgen O. Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell transplantation. Leukemia 2001; 15: 1976-1985.
10. Gardiner N, Lawler M, Riordan J, DeArce M, McCann SR. Monitoring of lineage specific chimerism allows early prediction of response following donor lymphocyte infusion for relapsed chronic myeloid leukemia. Bone Marrow Transplant 1998; 21: 711-719.
11. Zetterquist H, Mattsson J, Uzunel M, Nasman-Bjork I, Svenberg P, Tammik L, Bayat C, Winiarski J, Ringden O. Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia. Bone Marrow Transplant 2000; 25: 843-851.
12. Seidl C, Müller S, Jäger O, Seifried E. Sequence analysis and population data of short tandem repeat polymorphisms at loci D8S639 and D11S488. Int J Legal Med 1999; 112: 355-359.
13. Thiede C, Florek M, Bornhäuser M, Ritter M, Mohr B, Brendel C, Ehninger G, Neubauer A. Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection. Bone Marrow Transplant 1999; 23: 1055-1060.
14. Hantschel M, Hausmann R, Lederer T, Martus P, Betz P. Population genetics of nine short tandem repeat (STR) loci - DNA typing using the AmpFISTR Profiler PCR amplification kit. Int J Legal Med 1999; 112: 293-395.
15. Binda S, Borer UV, Gehrig C, Hochmeister M, Budowle B. Swiss Caucasian population data for the STR loci D2S1338 and D19S433 using AmpFISTR SGM Plus PCR amplification kit. Forensic Sci Int 2000; 108: 117-120.
16. Scharf SJ, Smith AG, Hansen JA, McFarland C, Erlich HA. Quantitative determination of bone marrow transplantation engraftment using fluorescent polymerase chain reaction primers for human identity markers. Blood 1995; 85: 1954-1963.
17. Jones DA. Blood samples: probability of discrimination. J Forensic Sci Soc 1972; 12: 355-359.
18. Nei M, Roychoudhury AK. Sampling variance of heterozygosity and genetic distance. Genetics 1974; 76: 379-390.
19. Woolsen RF. Statistical Methods for the Analysis of Biomedical data. Wiley: New York, 1987.
20. Mullokandov M, Class I, Achary PM, Klinger HP. Assignment of ACTBP8 (alias ACTBP2) within close to human chromosome band 6q13 using a radiation hybrid panel. Cytogenet Cell Genet 1997; 78: 46-47.
21. Klingebiel T, Niethammer D, Dietz K, Bader P. Progress in chimerism analysis in childhood malignancies: the dilemma of biostatistical considerations and ethical implications. Leukemia 2001; 15: 1989-1991.
22. Choi SJ, Lee KH, Lee JH, Kim S, Chung HJ, Lee JS, Park CJ, Chi HS, Kim WK. Prognostic value of hematopoietic chimerism in patients with acute leukemia after allogeneic bone marrow transplantation: a prospective study. Bone Marrow Transplant 2000; 26: 327-332.
23. Shimoni A, Nagler A. Non-myeloablative stem cell transplantation (NST): chimerism testing as guidance for immune-therapeutic manipulations. Leukemia 2001; 15: 1967-1975.
24. Lion T, Muller-Berat N. Chimerism testing after allogeneic stem cell transplantation: importance of timing and optimal techniques for testing in different clinical-biological situations. Leukemia 1999; 13: 2059.
25. Lion T. Chimerism testing after allogeneic stem cell transplantation: Importance of timing and optimal techniques for testing in different clinical-biological situations. Leukemia 2001; 15: 292.
26. Lion T, Muller-Berat N. Chimerism testing after allogeneic stem cell transplantation: importance of timing and optimal techniques for testing in different clinical-biological situations. Leukemia 2001; 15: 1966.
27. Polymeropoulos MH, Xiao H, Rath DS, Merril CR. Tetranucleotide repeat polymorphism at the human aromatase cytochrome P-450 gene (CYP19). Nucleic Acids Res 1991; 19: 195.
28. Polymeropoulos MH, Xiao H, Rath DS, Merril CR. Tetranucleotide repeat polymorphism at the human prostatic acid phosphatase (ACPP) gene. Nucleic Acids Res 1991; 19: 4792.